-
methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1(26),2(6),7(27),8,10,12,20(25),21,23-nonaene-16-carboxylate
-
ChemBase ID:
154113
-
Molecular Formular:
C27H21N3O5
-
Molecular Mass:
467.47274
-
Monoisotopic Mass:
467.14812079
-
SMILES and InChIs
SMILES:
C[C@@]12[C@](C[C@H](O1)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3C(=O)NC1)(C(=O)OC)O
Canonical SMILES:
COC(=O)[C@@]1(O)C[C@@H]2O[C@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
InChI:
InChI=1S/C27H21N3O5/c1-26-27(33,25(32)34-2)11-18(35-26)29-16-9-5-3-7-13(16)20-21-15(12-28-24(21)31)19-14-8-4-6-10-17(14)30(26)23(19)22(20)29/h3-10,18,33H,11-12H2,1-2H3,(H,28,31)/t18?,26-,27-/m0/s1
InChIKey:
KOZFSFOOLUUIGY-BEJFKGIZSA-N
-
Cite this record
CBID:154113 http://www.chembase.cn/molecule-154113.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1(26),2(6),7(27),8,10,12,20(25),21,23-nonaene-16-carboxylate
|
|
|
IUPAC Traditional name
|
methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1(26),2(6),7(27),8,10,12,20(25),21,23-nonaene-16-carboxylate
|
|
|
Synonyms
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
10.71429
|
H Acceptors
|
4
|
H Donor
|
2
|
LogD (pH = 5.5)
|
3.4832048
|
LogD (pH = 7.4)
|
3.4829972
|
Log P
|
3.4832075
|
Molar Refractivity
|
126.1198 cm3
|
Polarizability
|
53.223053 Å3
|
Polar Surface Area
|
94.72 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
K2015
|
Physical form Supplied as a 0.2 μm-filtered 1 mM solution in dimethyl sulfoxide (DMSO). Biochem/physiol Actions K-252a is also a specific inhibitor of Trk (tyrosine kinase) receptors and selectively blocks the effect of nerve growth factor.1 At lower concentrations, K-252a acts as a neuroprotective compound prompting survival of primary neuronal cultures.2 K-252a induces cell cycle arrest and apoptosis by inhibiting both Cdc2 and Cdc25c.3 K-252a improves psoriasis in a SCID mouse-human skin model4 and also suppresses referred mechanical hypersensitivity and neuropeptide up-regulation associated with acute pancreatitis.5 |
PATENTS
PATENTS
PubChem Patent
Google Patent